Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) saw a significant decrease in short interest in August. As of August 31st, there was short interest totaling 16,357 shares, a decrease of 56.2% from the August 15th total of 37,364 shares. Currently, 1.4% of the shares of the company are sold short. Based on an average trading volume of 272,520 shares, the short-interest ratio is currently 0.1 days.

Advanced Biomed Trading Up 3.9%

Shares of ADVB stock traded up $0.30 on Tuesday, hitting $8.08. 15,176 shares of the stock were exchanged, compared to its average volume of 845,635. The firm has a market capitalization of $13.33 million, a PE ratio of 1.68 and a beta of -0.29. Advanced Biomed has a one year low of $3.61 and a one year high of $24.23. The firm’s 50 day moving average is $8.61 and its two-hundred day moving average is $6.17.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ADVB shares. Wall Street Zen upgraded Advanced Biomed to a “hold” rating in a report on Saturday, August 22nd. Weiss Ratings raised Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, July 23rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Advanced Biomed has a consensus rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.